Optiver Holding’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Optiver Holding’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$790	Hold	3,200	–	–	﹤0.01%	2097
2025 Q4	$1.34K	Hold	3,200	–	–	﹤0.01%	2155
2025 Q3	$2.15K	Hold	3,200	–	–	﹤0.01%	2360
2025 Q2	$1.73K	Hold	3,200	–	–	﹤0.01%	1358
2025 Q1	$2.1K	Hold	3,200	–	–	﹤0.01%	1233
2024 Q4	$3.26K	Hold	3,200	–	–	﹤0.01%	905
2024 Q3	$2.77K	Hold	3,200	–	–	﹤0.01%	842
2024 Q2	$1.15K	Buy	+3,200	New	+$1.73K	﹤0.01%	861
2022 Q2	–	Sell	-1,442	Closed	-$8K	–	509
2022 Q1	$8K	Buy	1,442 +805	+126%	+$4.79K	﹤0.01%	441
2021 Q4	$5K	Buy	+637	New	+$5.53K	﹤0.01%	785

Other funds holding SGMO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Optiver Holding's SGMO Position: Q1 2026 in Review

Optiver Holding held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q1 2026 at 3,200 shares worth $790. The position accounts for ﹤0.01% of the portfolio, ranked #2097.

Optiver Holding first reported a position in SGMO in Q4 2021 and has held it in 10 quarters since. The position peaked at $8K in Q1 2022. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

Optiver Holding held 3,200 shares of SANGAMO THERAPEUTICS INC worth $790 as of Q1 2026.
Optiver Holding left its SANGAMO THERAPEUTICS INC share count unchanged in Q1 2026.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2097 holding.
Optiver Holding first reported a position in SANGAMO THERAPEUTICS INC in Q4 2021 and has held it in 10 quarters since.
Optiver Holding's SANGAMO THERAPEUTICS INC position peaked at $8K in Q1 2022.
112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.